|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
Decibel Therapeutics, Inc. (DBTX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
22 |
|
|
Total
Direct Shares :
|
2,291,412 |
|
Total
Indirect Shares :
|
10,555,854 |
|
%
Held by Insiders:
|
9.2% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Exter Neil |
Director, 10% Owner |
2021-02-17 |
0 |
2021-02-17 |
3,139,685 |
Glaxosmithkline Plc |
Director |
2021-02-17 |
0 |
2021-02-17 |
1,183,663 |
Foy Matthew |
Director, 10% Owner |
2021-02-17 |
0 |
2021-02-17 |
1,183,663 |
Casdin Partners Master Fund, L.p. |
10% Owner |
2021-02-17 |
0 |
2021-02-17 |
1,121,421 |
Thompson Peter A |
Director, 10% Owner |
2021-02-17 |
0 |
2021-02-17 |
883,418 |
Orbimed Capital Llc |
Director, 10% Owner |
2021-02-17 |
0 |
2021-02-17 |
883,418 |
Gv 2019, L.p. |
10% Owner |
2021-02-17 |
0 |
2021-02-17 |
819,631 |
Schroder Adveq Cpl Global Management Iii L.p. |
10% Owner |
2021-02-17 |
0 |
2021-02-17 |
524,328 |
Gv 2017, L.p. |
10% Owner |
2021-02-17 |
0 |
2021-02-17 |
494,649 |
Gv 2016, L.p. |
10% Owner |
2021-02-17 |
0 |
2021-02-17 |
321,978 |
Regeneron Pharmaceuticals Inc |
10% Owner |
2021-02-17 |
2,097,314 |
2021-02-17 |
0 |
Longevity Fund 2 Lp |
10% Owner |
2021-02-17 |
79,143 |
2021-02-17 |
0 |
Nochur Sara |
Director |
2023-09-25 |
0 |
2023-06-13 |
0 |
Reid Laurence |
See Remarks, Director |
2023-09-25 |
0 |
2021-09-15 |
0 |
Carson William H. |
Director |
2023-09-25 |
0 |
2023-06-13 |
0 |
Finger Alison Cecily |
Director |
2023-09-25 |
0 |
2023-06-13 |
0 |
Mclaughlin Kevin F |
Director |
2023-09-25 |
0 |
2023-06-13 |
0 |
Kapusta Matthew C |
Director |
2023-09-25 |
0 |
2023-03-19 |
0 |
Steven H. Holtzman Revocable Trust |
10% Owner |
2021-02-11 |
67,786 |
|
0 |
Tepper Robert I |
10% Owner |
2021-02-11 |
47,169 |
|
0 |
Trask Anna |
Chief People Officer |
2023-09-25 |
0 |
|
0 |
Lee John Jui-Jen |
Chief Development Officer |
2023-09-25 |
0 |
|
0 |
|
|